Chapin Davis Inc. Sells 85 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Chapin Davis Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,616 shares of the healthcare conglomerate’s stock after selling 85 shares during the period. Chapin Davis Inc.’s holdings in UnitedHealth Group were worth $945,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Bell Investment Advisors Inc lifted its holdings in shares of UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares during the period. Harbor Investment Advisory LLC lifted its stake in UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares during the last quarter. Austin Private Wealth LLC lifted its stake in UnitedHealth Group by 9.8% in the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares during the last quarter. Capital Insight Partners LLC lifted its stake in UnitedHealth Group by 3.8% in the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the last quarter. Finally, Collective Family Office LLC increased its position in UnitedHealth Group by 4.3% in the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after acquiring an additional 65 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $583.58 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The stock has a market cap of $537.12 billion, a PE ratio of 35.67, a P/E/G ratio of 1.65 and a beta of 0.58. The firm has a 50 day simple moving average of $582.24 and a two-hundred day simple moving average of $527.84.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the prior year, the company earned $6.14 EPS. The firm’s revenue was up 6.4% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group’s payout ratio is currently 51.34%.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Royal Bank of Canada raised their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.